JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EVAV
4601
DELISTED
Direxion Daily Electric and Autonomous Vehicles Bull 2X Shares
EVAV
| $296K | ﹤0.01% |
5,000
| – | – |
2022 Q3
1 quarter
|
|
|
WBX
4602
Wallbox
WBX
$65M
| $296K | ﹤0.01% |
4,133
+89
| +2% | +$10.1K |
2021 Q4
4 quarters
|
|
4603
Farmers National Banc Corp
FMNB
$902M
| $295K | ﹤0.01% |
20,931
-86,212
| -80% | -$1.22M |
2015 Q4
28 quarters
|
|
|
RESD
4604
DELISTED
WisdomTree International ESG Fund
RESD
| $294K | ﹤0.01% |
+11,614
| New | +$281K |
2022 Q4
0 quarters
|
|
4605
ClearPoint Neuro
CLPT
$336M
| $292K | ﹤0.01% |
34,499
+1,693
| +5% | +$16K |
2019 Q3
13 quarters
|
|
4606
Amplify Alternative Harvest ETF
MJ
$103M
| $292K | ﹤0.01% |
+5,715
| New | +$354K |
2022 Q4
0 quarters
|
|
4607
Southern Missouri Bancorp
SMBC
$789M
| $292K | ﹤0.01% |
6,358
+2,071
| +48% | +$104K |
2017 Q4
20 quarters
|
|
4608
iShares 10-20 Year Treasury Bond ETF
TLH
$10.7B
| $292K | ﹤0.01% |
2,698
+1,254
| +87% | +$136K |
2019 Q2
14 quarters
|
|
4609
Gilat Satellite Networks
GILT
$710M
| $291K | ﹤0.01% |
50,256
-11,060
| -18% | -$62.6K |
2019 Q3
13 quarters
|
|
4610
Franklin International Low Volatility High Dividend Index ETF
LVHI
$5.89B
| $291K | ﹤0.01% |
+11,407
| New | +$292K |
2022 Q4
0 quarters
|
|
4611
Pliant Therapeutics
PLRX
$63.8M
| $290K | ﹤0.01% |
14,959
-22,012
| -60% | -$460K |
2020 Q3
9 quarters
|
|
4612
PUT
Penumbra
PEN
$12.5B
| $289K | ﹤0.01% |
1,300
-2,700
| -68% | -$528K |
2022 Q3
1 quarter
|
|
|
NESR
4613
National Energy Services Reunited Corp
NESR
$2.47B
| $289K | ﹤0.01% |
41,623
-40,839
| -50% | -$270K |
2019 Q1
15 quarters
|
|
4614
Bausch Health
BHC
$2.25B
| $288K | ﹤0.01% |
45,847
-966,385
| -95% | -$6.75M |
2013 Q2
38 quarters
|
|
4615
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.3B
| $288K | ﹤0.01% |
12,848
-9,208
| -42% | -$200K |
2013 Q2
38 quarters
|
|
|
ORGN
4616
DELISTED
Origin Materials
ORGN
| $288K | ﹤0.01% |
2,082
+153
| +8% | +$24.4K |
2021 Q4
4 quarters
|
|
|
FIRY
4617
Firy Inc
FIRY
$207M
| $288K | ﹤0.01% |
28,391
+11,841
| +72% | +$218K |
2020 Q3
9 quarters
|
|
4618
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$270M
| $288K | ﹤0.01% |
+8,319
| New | +$286K |
2022 Q4
0 quarters
|
|
|
MCBC
4619
DELISTED
Macatawa Bank Corp
MCBC
| $288K | ﹤0.01% |
26,165
+11,137
| +74% | +$118K |
2015 Q4
28 quarters
|
|
|
BBUC
4620
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.38B
| $286K | ﹤0.01% |
15,253
+1,041
| +7% | +$22.6K |
2022 Q1
3 quarters
|
|
4621
Cellebrite
CLBT
$2.86B
| $286K | ﹤0.01% |
65,578
+9,162
| +16% | +$40.9K |
2021 Q3
5 quarters
|
|
4622
Eos Energy Enterprises
EOSE
$1.19B
| $286K | ﹤0.01% |
193,186
-31,279
| -14% | -$40.5K |
2021 Q2
6 quarters
|
|
4623
CALL
Ralph Lauren
RL
$22B
| $285K | ﹤0.01% |
+2,700
| New | +$270K |
2022 Q4
0 quarters
|
|
|
OYST
4624
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $285K | ﹤0.01% |
25,532
+23,817
| +1,389% | +$231K |
2019 Q4
12 quarters
|
|
|
AVDL
4625
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
| $284K | ﹤0.01% |
39,700
-15,800
| -28% | -$111K |
2022 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.